Mirae Asset Securities (Usa) Inc. Tg Therapeutics, Inc. Transaction History
Mirae Asset Securities (Usa) Inc.
- $3.63 Trillion
- Q1 2025
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 180,752 shares of TGTX stock, worth $6.07 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
180,752Holding current value
$6.07 Million% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$383 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$250 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$110 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$95.6 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.88B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...